New Results
Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence
View ORCID ProfileLaura McCulloch, View ORCID ProfileStuart M. Allan, View ORCID ProfileCraig J. Smith, View ORCID ProfileBarry W. McColl
doi: https://doi.org/10.1101/587881
Laura McCulloch
1UK Dementia Research Institute, University of Edinburgh, Edinburgh, United Kingdom
Stuart M. Allan
2Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Craig J. Smith
3Division of Cardiovascular Sciences, University of Manchester, Manchester, UK and Greater Manchester Comprehensive Stroke Centre, Manchester Centre for Clinical Neurosciences, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, UK
Barry W. McColl
1UK Dementia Research Institute, University of Edinburgh, Edinburgh, United Kingdom
Article usage
Posted March 26, 2019.
Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence
Laura McCulloch, Stuart M. Allan, Craig J. Smith, Barry W. McColl
bioRxiv 587881; doi: https://doi.org/10.1101/587881
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)